1,287
Participants
Start Date
February 2, 2021
Primary Completion Date
February 15, 2024
Study Completion Date
December 29, 2028
Abelacimab
Abelacimab provided as liquid in vial (150 mg/mL)
Rivaroxaban
Rivaroxaban 15 mg and 20 mg provided as commercially available film-coated tablets
Anthos Investigative Site, Taipei
Anthos Investigative Site, Tiachung
Anthos Investigative Site, Kaohsiung City
Anthos Investigative Site, Hualien City
Anthos Investigative Site, Budapest
Anthos Investigative Site, Budapest
Anthos Investigative Site, Budapest
Anthos Investigative Site, Budapest
Anthos Investigative Site, Seoul
Anthos Investigative Site, Seoul
Anthos Investigative Site, Debrecen
Anthos Investigative Site (4002), Nyíregyháza
Anthos Investigative Site (4003), Nyíregyháza
Anthos Investigative Site, Orosháza
Anthos Investigative Site, Baja
Anthos Investigative Site, Kaposvár
Anthos Investigative Site, Székesfehérvár
Anthos Investigative Site, Balatonfüred
Anthos Investigative Site, Balatonfüred
Anthos Investigative Site, Prague
Anthos Investigative Site, Taipei
Anthos Investigative Site, Southampton
Anthos Investigative Site, Poughkeepsie
Anthos Investigative Site, Seongnam-si
Anthos Investigative Site, Seongnam-si
Anthos Investigative Site, Camp Hill
Anthos Investigative Site, Manassas
Anthos Investigative Site, Salisbury
Anthos Investigative Site, Falls Church
Anthos Investigative Site, Yilan
Anthos Investigative Site, Lenoir
Anthos Investigative Site, Poděbrady
Anthos Investigative Site, Johns Creek
Anthos Investigative Site, Taipei
Anthos Investigative Site, Saint Augustine
Anthos Investigative Site, Clearwater
Anthos Investigative Site, Largo
Anthos Investigative Site, Safety Harbor
Anthos Investigative Site, Huntsville
Anthos Investigative Site, Mobile
Anthos Investigative Site, Kingsport
Anthos Investigative Site, Owensboro
Anthos Investigative Site, Lansing
Anthos Investigative Site, Seogu
Anthos Investigative Site, Fargo
Anthos Investigative Site, Oklahoma City
Anthos Investigative Site, Kingwood
Anthos Investigative Site, Tomball
Anthos Investigative Site, Stamford
Anthos Investigative Site, Daytona Beach
Anthos Investigative Site, Baltimore
Anthos Investigative Site, Framingham
Anthos Investigative Site, Haverhill
Anthos Investigative Site, Sewell
Anthos Investigative Site, Odessa
Anthos Investigative Site, Cambridge
Anthos Investigative Site, Greater Sudbury
Anthos Investigative Site, Oshawa
Anthos Investigative Site, Greenfield Park
Anthos Investigative Site, Montreal
Anthos Investigative Site, Brandýs nad Labem
Anthos Investigative Site, Příbram
Anthos Investigative Site, Slaný
Anthos Investigative Site, Mariánské Lázně
Anthos Investigative Site, Trutnov
Anthos Investigative Site, Liberec
Anthos Investigative Site, Liberec
Anthos Investigative Site, Česká Lípa
Anthos Investigative Site, Pardubice
Anthos Investigative Site, Prague
Anthos Investigative Site, Prague
Anthos Investigative Site, Kroměříž
Anthos Investigative Site, Holešov
Anthos Investigative Site, Gdynia
Anthos Investigative Site, Chrzanów
Anthos Investigative Site, Krakow
Anthos Investigative Site, Wroclaw
Anthos Investigative Site, Żarów
Anthos Investigative Site, Lublin
Anthos Investigative Site, Zamość
Anthos Investigative Site, Płock
Anthos Investigative Site, Warsaw
Anthos Investigative Site, Warsaw
Anthos Investigative Site, Przemyśl
Anthos Investigative Site, Gdynia
Anthos Investigative Site, Bielsko-Biala
Anthos Investigative Site, Dąbrowa Górnicza
Anthos Investigative Site, Ruda Śląska
Anthos Investigative Site, Tychy
Anthos Investigative Site, Elblag
Anthos Investigative Site, Lodz
Anthos Investigative Site, Seoul
Lead Sponsor
Collaborators (1)
The TIMI Study Group
OTHER
Fortrea
INDUSTRY
Anthos Therapeutics, Inc.
INDUSTRY